Protein kinase (PK) (PK)

Protein kinases are a large and diverse family of enzymes that catalyze the transfer of a gamma-phosphate group from ATP to specific amino acid residues—typically serine, threonine, or tyrosine—on target proteins (Source: UniProt, 2023). This process, known as phosphorylation, serves as a fundamental regulatory mechanism that alters the function, localization, and stability of proteins, thereby governing nearly every aspect of cellular life (Source: NIH, 2022). Kinases function as critical nodes in signal transduction pathways, translating extracellular signals into coordinated intracellular responses such as cell growth, division, and metabolism (Source: Nature Reviews Molecular Cell Biology, 2022). Dysregulation of kinase activity, frequently caused by genetic mutations, chromosomal translocations, or protein overexpression, is a central driver in the development of various pathologies, including many types of cancer, inflammatory diseases, and metabolic disorders (Source: Nature Reviews Drug Discovery, 2021). Consequently, kinases represent one of the most significant classes of therapeutic targets, with numerous small-molecule inhibitors and monoclonal antibodies developed to modulate their activity (Source: StatPearls, 2023). These therapeutic agents typically work by competing with ATP for the binding site or by inducing conformational changes that inhibit enzymatic function, providing a cornerstone for modern precision medicine (Source: PubMed, 2022). Despite their success, challenges such as the development of drug resistance through secondary mutations and off-target toxicities remain significant hurdles in clinical practice (Source: Journal of Clinical Oncology, 2021).

Other names

KinasePhosphotransferaseTyrosine kinaseSerine-threonine kinaseDual-specificity kinase

Kinase inhibitors primarily function through several distinct mechanisms: 1) Type I inhibitors bind to the active conformation of the kinase in the ATP-binding pocket; 2) Type II inhibitors bind to the inactive conformation, often occupying the ATP pocket and an adjacent allosteric site; 3) Type III and IV inhibitors bind to allosteric sites outside the ATP pocket to modulate activity; and 4) Type V inhibitors form irreversible covalent bonds with cysteine residues within or near the active site (Source: Nature Reviews Drug Discovery, 2021; StatPearls, 2023).